NSE · HIKAL.NS
Hikal Limited
₹213.36+₹8.96 (+4.38%)
Hikal Limited’s quoted price sits in the upper half of its reported 52-week range, 18.28% below the high.
Loading market information…
BSE · TYCHE.BO · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:19 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Tyche Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 29.86% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Tyche Industries Limited’s forward annual dividend is ₹3.50 per share, paid annual. The forward yield is 3.37% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Tyche Industries Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Tyche Industries Ltd. focuses on the production and refinement of active pharmaceutical compounds and their chemical precursors. The company's diverse product line includes specialized chiral intermediates and various nutraceuticals, all intended for use in treating a wide array of medical conditions. Established on July 23, 1998, the enterprise maintains its primary operations from its headquarters in Hyderabad, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:09 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹213.36+₹8.96 (+4.38%)
Hikal Limited’s quoted price sits in the upper half of its reported 52-week range, 18.28% below the high.
₹281.00+₹3.00 (+1.08%)
Infinium Pharmachem Ltd.’s quoted price sits in the upper half of its reported 52-week range, 13.41% below the high.
₹9.06+₹0.10 (+1.12%)
Gennex Laboratories Limited’s quoted price sits in the lower half of its reported 52-week range, 46.67% below the high.
₹33.75-₹1.51 (-4.28%)
Syschem (India) Limited’s quoted price sits in the lower half of its reported 52-week range, 44.63% below the high.
₹140.00-₹2.55 (-1.79%)
Smruthi Organics Limited’s quoted price sits in the upper half of its reported 52-week range, 20.14% below the high.
₹31.20+₹0.75 (+2.46%)
Kimia Biosciences Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.91% below the high.
₹232.65-₹0.10 (-0.04%)
Auro Laboratories Limited’s quoted price sits in the lower half of its reported 52-week range, 26.61% below the high.
₹82.00-₹2.61 (-3.08%)
Bal Pharma Limited’s quoted price sits in the lower half of its reported 52-week range, 34.19% below the high.
